GREENLAND MINES LTD Fair Value Adjustment of Warrants
GREENLAND MINES LTD (GRML) reported Fair Value Adjustment of Warrants of -$1.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-17
- GREENLAND MINES LTD fair value adjustment of warrants for the quarter ending 2026-06-30 was -$1.82M, a 1594.31% decline year-over-year.
- GREENLAND MINES LTD fair value adjustment of warrants for the quarter ending 2026-03-31 was $2.31M.
- GREENLAND MINES LTD fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- GREENLAND MINES LTD fair value adjustment of warrants for the quarter ending 2025-09-30 was -$79.45K.
- GREENLAND MINES LTD fair value adjustment of warrants for fiscal 2025 was $28.51K, a 1354.05% increase from fiscal 2024.
- GREENLAND MINES LTD fair value adjustment of warrants for fiscal 2024 was $1.96K, a 92.60% decline from fiscal 2023.
- GREENLAND MINES LTD fair value adjustment of warrants for fiscal 2023 was $26.50K.
- GREENLAND MINES LTD fair value adjustment of warrants for fiscal 2022 was -$555.92K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.82M 10-Q · filed 2026-08-17 | $499.12K 10-Q · filed 2026-08-17 | $499.12K derived: sum of 3 quarters · filed 2026-08-17 | $419.67K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $2.31M 10-Q/A · filed 2026-08-14 | $2.31M derived: sum of 2 quarters · filed 2026-08-14 | $2.23M derived: sum of 3 quarters · filed 2026-08-14 | $2.36M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | -$79.45K derived: sum of 2 quarters · filed 2026-08-14 | $42.03K derived: sum of 3 quarters · filed 2026-08-17 | $28.51K 10-K/A · filed 2026-08-14 |
| 2025-09-30 | -$79.45K 10-Q · filed 2025-11-13 | $42.03K derived: sum of 2 quarters · filed 2026-08-17 | $28.51K 10-Q · filed 2025-11-13 | $31.80K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $121.48K 10-Q · filed 2026-08-17 | $107.96K 10-Q · filed 2026-08-17 | $111.25K derived: sum of 3 quarters · filed 2026-08-17 | $70.22K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$13.52K 10-Q/A · filed 2026-08-14 | -$10.23K derived: sum of 2 quarters · filed 2026-08-14 | -$51.25K derived: sum of 3 quarters · filed 2026-08-14 | -$11.55K derived: sum of 4 quarters · filed 2026-08-14 |
| 2024-12-31 | $3.29K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | -$37.74K derived: sum of 2 quarters · filed 2026-08-14 | $1.96K derived: sum of 3 quarters · filed 2026-08-14 | $1.96K 10-K/A · filed 2026-08-14 |
| 2024-09-30 | -$41.02K 10-Q · filed 2025-11-13 | -$1.32K derived: sum of 2 quarters · filed 2025-11-13 | -$1.32K 10-Q · filed 2025-11-13 | -$34.19K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $39.70K 10-Q · filed 2025-08-18 | $39.70K 10-Q · filed 2025-08-18 | $6.84K derived: sum of 3 quarters · filed 2025-08-18 | $17.44K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | -$16.96K 10-Q · filed 2024-05-23 | -$32.86K derived: sum of 2 quarters · filed 2024-05-23 | -$22.26K derived: sum of 3 quarters · filed 2024-05-23 | -$1.06K derived: sum of 4 quarters · filed 2024-05-23 |
| 2023-12-31 | -$15.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | -$5.30K derived: sum of 2 quarters · filed 2024-04-17 | $15.90K derived: sum of 3 quarters · filed 2024-04-17 | $26.50K 10-K · filed 2024-04-17 |
| 2023-09-30 | $10.60K 10-Q · filed 2023-11-17 | $31.80K derived: sum of 2 quarters · filed 2023-11-17 | $42.40K 10-Q · filed 2023-11-17 | $42.40K derived: sum of 4 quarters · filed 2024-05-23 |
| 2023-06-30 | $21.20K 10-Q · filed 2023-08-21 | $31.80K 10-Q · filed 2023-08-21 | $31.80K derived: sum of 3 quarters · filed 2024-05-23 | -$646.60K derived: sum of 4 quarters · filed 2024-05-23 |
| 2023-03-31 | $10.60K 10-Q · filed 2024-05-23 | $10.60K derived: sum of 2 quarters · filed 2024-05-23 | -$667.80K derived: sum of 3 quarters · filed 2024-05-23 | -$545.32K derived: sum of 4 quarters · filed 2024-05-23 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | -$678.40K derived: sum of 2 quarters · filed 2024-04-17 | -$555.92K derived: sum of 3 quarters · filed 2024-04-17 | -$555.92K 10-K · filed 2024-04-17 |
| 2022-09-30 | -$678.40K 10-Q · filed 2023-11-17 | -$555.92K derived: sum of 2 quarters · filed 2023-11-17 | -$555.92K 10-Q · filed 2023-11-17 | |
| 2022-06-30 | $122.48K 10-Q · filed 2023-08-21 | $122.48K 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |